Chlorhexidine-silver sulfadiazine-impregnated central venous catheters for femoral access

0

“…patients with chlorhexidine-silver sulfadiazine-impregnated catheters had a lower rate of catheter-related bloodstream infection…” Lorente et al (2014).

Reference:

Lorente, L., Lecuona, M., Jiménez, A., Lorenzo, L., Diosdado, S., Marca, L. and Mora, M.L. (2014) Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. American Journal of Infection Control. 42(10), p.1130-2.

Abstract:

Sixty-four patients with chlorhexidine-silver sulfadiazine-impregnated catheters had a lower rate of catheter-related bloodstream infection and lower central venous catheter-related costs per catheter day than 190 patients with a standard catheter.

Thank you to our partners for supporting IVTEAM

Main page

Share.

Comments are closed.